Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye‐Ogala, David James VanderWeele, Berkley E. Gryder et al.|Molecular Cancer Therapeutics|2020Cited by 55
Targeting the PI3K/AKT pathway overcomes enzalutamide resistance by inhibiting induction of the glucocorticoid receptorRemi Adelaiye‐Ogala, David James VanderWeele, Berkley E. Gryder et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 5
Data from Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye‐Ogala, David James VanderWeele, Berkley E. Gryder et al.|Unknown|2023Cited by 0
Data from Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye‐Ogala, David James VanderWeele, Berkley E. Gryder et al.|Unknown|2023Cited by 0
Supplementary Table 1 and Figure S1- S8 from Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye‐Ogala, David James VanderWeele, Berkley E. Gryder et al.|Unknown|2023Cited by 0